Patents by Inventor E. Sabrinah Chapman-Montgomery

E. Sabrinah Chapman-Montgomery has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Reduction of platelet interference in plasma assay samples
    Patent number: 7767465
    Abstract: The present invention relates to compositions for improving assay accuracy for plasma samples by decreasing or eliminating false results due to platelet interference. The compositions of the present invention comprise compositions that include a platelet interference reducing agent in an amount effective to decrease the platelet interference activity in the plasma sample, particularly platelet-rich plasma sample, to be analyzed. The most preferred platelet interference reducing agent of the present invention is 1-(1,3-Bis(hydroxymethyl-2,5-dioxoimidazolidin-4-iyl)-1,3-bis(hydroxymethyl) urea, also called “Diazolidinyl urea” or “DZU”.
    Type: Grant
    Filed: March 13, 2007
    Date of Patent: August 3, 2010
    Assignee: Siemens Healthcare Diagnostics Inc
    Inventors: Bin Zhang, E. Sabrinah Chapman-Montgomery, Edward P. Kang
  • PLATELET ACTIVATION MARKERS AS INDICATORS FOR ANTI-PLATELET THERAPY
    Publication number: 20100173339
    Abstract: Methods for determining the appropriateness of anti-platelet therapy in a patient with a platelet-affected disease. The Mean Platelet Component value in a patient blood sample is determined corresponding to the patient's platelet activation status. A high platelet activation status indicates the appropriateness of anti-platelet therapy.
    Type: Application
    Filed: March 22, 2010
    Publication date: July 8, 2010
    Applicant: Siemens Healthcare Diagnostics Inc.
    Inventors: E. Sabrinah Chapman-Montgomery, David Okrongly, Andrew McGregor Grant, Charaf E. Ahnadi, Alan Wu, Andre Gervais
  • Methods for monitoring patients for efficacy of an antiplatelet therapy regimen
    Patent number: 7723064
    Abstract: Methods are disclosed for monitoring patients utilizing Mean Platelet Component values during therapeutic intervention.
    Type: Grant
    Filed: July 26, 2005
    Date of Patent: May 25, 2010
    Assignee: Siemens Healthcare Diagnostics Inc.
    Inventors: E. Sabrinah Chapman-Montgomery, David Okrongly, Andrew McGregor Grant, Charaf E. Ahnadi, Alan Wu, Andre Gervais
  • Platelet Activation Markers and Predictors of Desease and of Response to Therapy and for Monitoring Therapeutic Progress
    Publication number: 20080311606
    Abstract: Methods for assessing patient risk for platelet-affected disease states are disclosed. Also disclosed are methods for predicting the appropriateness of platelet antagonist therapy, and for monitoring patients during therapeutic intervention or during a combined regimen of therapy and angioplasty.
    Type: Application
    Filed: July 26, 2005
    Publication date: December 18, 2008
    Applicant: Bayer Healthcare LLC
    Inventors: E. Sabrinah Chapman- Montgomery, David Okrongly, Andrew McGregor Grant, Charaf E. Ahnadi, Alan Wu, Andre Gervais